Biodegradable polymer drug-eluting stents: caveat emptor

Lancet. 2017 Oct 21;390(10105):1814-1816. doi: 10.1016/S0140-6736(17)32668-5. Epub 2017 Oct 19.

Authors

Robert A Byrne¹, Tibor Schuster²

Affiliations

¹ Deutsches Herzzentrum München, Technische Universität München, D-80636 Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany. Electronic address: byrne@dhm.mhn.de.
² Department of Family Medicine, McGill University, Montreal, QC, Canada.

PMID: 29082870
DOI: 10.1016/S0140-6736(17)32668-5

No abstract available

Publication types

Comment

MeSH terms

Absorbable Implants
Coronary Artery Disease
Drug-Eluting Stents*
Everolimus*
Percutaneous Coronary Intervention
Polymers
Prosthesis Design
Sirolimus
Treatment Outcome

Substances

Polymers
Everolimus
Sirolimus